NEW YORK, Aug. 1 - Dharmacon's new deal to provide Abbott with a library of short-interfering RNAs for drug target genes is not just another gold star for the company, according to Stephen Scaringe, who has recently taken a new title of Chief Scientific officer and co-chairman.

 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.